OpenEvidence launches free Access Intelligence for clinicians

By Daniel Okafor

OpenEvidence launched Access Intelligence on November 11, 2026, giving all clinicians free access to tools covering more than 2,500 patient-support programs. OpenEvidence built the suite directly into its clinical AI platform. Clinicians could use it immediately at no charge.

The product targets the work that follows a treatment decision. OpenEvidence says determining whether a patient can afford and obtain the recommended care remains fragmented across thousands of sources, payers and formats, each with its own forms, criteria and paperwork. Clinicians often must absorb that complexity during the few minutes available with a patient, or leave it unaddressed.

What problem does Access Intelligence solve?

Ania Bilski, MD, OpenEvidence’s VP of Clinical AI, said the company’s goal is to close that gap. “Choosing the right treatment should be the hard part. Getting the patient access to it shouldn’t be.”

Access Intelligence places affordability and coverage tasks beside the clinical evidence used to select treatment, extending the platform beyond clinical guidance into coverage administration. Both stages now share one platform. A clinician can move from a recommended treatment toward a support program without leaving the clinical environment for a separate benefits search.

How does program discovery and enrollment work?

OpenEvidence says Access Intelligence covers three categories:

• Copay savings.
• Patient assistance.
• Insurance support services.

The company updates program information daily.

Clinicians can ask about program availability and patient eligibility inside the platform, then download a prepopulated form when both clinician and patient enrollment is required. They may also complete the enrollment process directly on OpenEvidence. The direct option handles both the search for assistance and part of the paperwork required to secure it.

In practical terms, the workflow resembles moving a paper packet from several filing cabinets onto one screen. The platform keeps discovery and enrollment within the same clinical system.

How do patients receive savings information?

Clinicians can send copay savings and discount offers to patients through Patient TakeHome. The distribution feature predated Access Intelligence. OpenEvidence introduced Patient Take-Homes on August 19, 2026, as an optional way for physicians to turn selected answers into patient educational handouts.

Patients receive a secure email link. They can share the curated material with family members or caregivers. They cannot ask their own questions through TakeHome. Physicians retain control over what is shared and whether to share anything at all.

That makes TakeHome a delivery channel for savings information. It carries selected clinical answers into patient communication while leaving the physician in control of distribution.

How does prior-authorization drafting work?

OpenEvidence reports that clinicians had already written more than 500,000 prior-authorization documents on the platform before this launch. Access Intelligence grounds prior-authorization requests, appeal letters and letters of medical necessity in available clinical guidelines and best practices.

The generated materials can also include:

• Prior-authorization checklists.
• Relevant ICD-10 codes.

Clinicians can edit generated letters directly in OpenEvidence. On the platform’s Sackett and Snow models, they can work through letters interactively, using follow-up questions to surface details reviewers look for. That extends documentation beyond producing an initial draft. Clinicians can refine the wording and develop supporting material within the same platform.

Will the integrated workflow reduce delays?

Access Intelligence combines program discovery, savings distribution, enrollment and iterative authorization drafting in one clinical environment. The open question is whether that integration will reduce administrative delays after a clinical decision. OpenEvidence’s next test is whether the combined workflow can reduce the gap between selecting treatment and securing patient access.

Free access makes the suite available to every clinician. It does not settle the operational question. The proof will be whether discovery, enrollment and authorization work as one sequence rather than four separate administrative tasks.